TP53 and lung adenocarcinoma: Future studies are needed to elucidate the possible mechanisms of interaction between the TP53 R337H variant and IL-1β signaling in the context of exposure to high levels of PM2.5 in the carcinogenesis of lung adenocarcinoma.